Ebix Q1 Diluted EPS Rose 24% to a Record $0.83 on Revenues of $79.1M


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Ebix Q1 Diluted EPS Rose 24% to a Record $0.83 on Revenues of $79.1M

Ebix Q1 Diluted EPS Rose 24% to a Record $0.83 on Revenues of $79.1M

JOHNS CREEK, GA--(Marketwired - May 9, 2017) -  Ebix, Inc. ( :), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, e-governance and healthcare industries, today reported results for its first quarter ended March 31, 2017. Ebix will host a conference call to review its results today at 11:00 a.m. EDT (details below).

Ebix delivered the following results for the first quarter of 2017:

Revenues: Q1 2017 revenue rose 11% to $79.1 million compared to $71.1 million in Q1 2016 and decreased 1% over Q4 2016 revenue of $80.0 million. The year over year revenue improvement reflected growth in the Company's Exchange, Risk Compliance, and Broker Solution channels.

On a constant currency basis, Ebix Q1 2017 revenue increased 10% to $78.5 million compared to $71.1 million in Q1 2016. The Exchange channel continued to be Ebix's largest, accounting for 67% of Q1 2017 revenues.

         
(dollar amounts in thousands)        
Channel   Q1 2017   Q1 2016   Change
Exchanges   $ 52,614   $ 50,086   +5 %
                   
Risk Compliance Solutions (RCS)    
21,852
    16,751   +30 %
                   
Broker Solutions     3,788     3,212   +18 %
Carrier Systems     849     1,017   -17 %
Total Revenue   $ 79,103   $ 71,066   +11 %
                   
Total Revenue on Constant Currency Basis   $ 78.5M   $ 71.1M   +10 %
                   

Earnings per Share: Q1 2017 diluted earnings per share increased 24% to $0.83 compared to $0.67 in Q1 2016, reflecting higher net income and the benefit of ongoing share repurchase activity. Ebix's weighted average diluted shares outstanding decreased to 32.0 million in Q1 2017 compared to 33.3 million in Q1 2016 and 32.5 million in Q4 2016.

Operating Cash: Cash generated from operations rose 49% to $15.7 million in Q1 2017 compared to $10.5 million in Q1 2016. Q1 2017 cash flows reflected cumulative cash payment of $8.95 million for bank interest and income tax, principally on account of non-recurring advance Minimum Alternate Tax (MAT) payments in India.

Operating Income and Margins: Q1 2017 operating margins decreased to 33% as compared to 35% in Q1 2016. Operating income for Q1 2017 rose 4% to $25.7 million compared to $24.8 million in Q1 2016.

Net Income: Q1 2017 net income rose 19% to $26.4 million, compared to $22.2 million in Q1 2016. The improvement principally reflected the benefit of higher revenues and operating income as compared to the same period last year.

Share Repurchases: In Q1 2017, Ebix repurchased 594,048 shares of its outstanding common stock for aggregate cash consideration of $34.2 million, not including 109,475 shares totaling $6.4 million repurchased in Q4 2016 that were settled in January 2017.

Q2 2017 Diluted Share Count: As of today, Ebix expects its diluted share count for Q2 2017 to be approximately 31.7 million.

Dividend: Ebix paid its regular quarterly dividend of $0.075 per share in Q1 2017 for a total cost of $2.4 million.

Ebix Chairman, President and CEO Robin Raina, said, "We are pleased to start 2017 on a consistent and strong note, with respect to revenue, net income and cash flow growth. The first quarter was strong from a business development standpoint as we agreed to undertake a few substantial deals that involve implementations that should contribute to our results over the balance of 2017. Considering one time seasonal revenue increases from the Continuing Education and Health administration exchange segments that contributed approximately $3 million in Q4 of 2016, we were pleased with our Q1 2017 performance on a sequential basis."

Robin added, "Ebix continues to review each of our business lines in terms of margin performance. From this disciplined review, we are able to focus our resources on our best performing opportunities as well as possibly reduce our focus on areas where margins are under pressure. Ebix continues to deploy increased man power on strategic opportunities such as our implementation of the PPL Reinsurance Exchange in London, and the underwriting exchanges in the US. These steps have not only contributed new consistent long term revenue streams but have also created tremendous goodwill for Ebix and a customer salesforce that helps us sell purely on the strength of our reference base. The growing customer awareness of Ebix's domain expertise and performance has opened up many new business opportunities -- deals that we would not have known about, had our customers not made the strong positive recommendations."

"From an M&A standpoint, we continue to pursue a few acquisition opportunities that in my view have the potential to be major growth drivers for Ebix. We hope to announce one such strategic acquisition soon," Robin said.

Sean Donaghy, Ebix CFO, said, "We are very pleased with the Company's continued ability to generate cash and fund its growth and investor friendly initiatives. In Q1 2017, we spent a total of $52.3 million on share buybacks, dividends, tax payments and building construction. Specifically, during the quarter, we used $40.5 million to repurchase 703,523 shares of Ebix common stock, paid $6.7 million of taxes, spent $2.7 million on building out our facilities in India and Johns Creek, GA, and paid dividends of $2.4 million, while drawing just $40.0 million from our Bank credit facilities. After these significant uses of cash, Ebix still ended the quarter with cash flow from operating activities of $15.7 million and $123.5 million of cash, cash equivalents, and short-term investments, an increase of $52.1 million as compared to March 31, 2016."

Conference Call Details:

Call Date/Time: Tuesday, May 9, 2017 at 11:00 a.m. EDT
Call Dial-In: +1-877-837-3909 or 1-973-409-9690; Call ID # 13609854
Live Audio Webcast: www.ebix.com/webcast
Audio Replay URL: www.ebix.com/result_17_Q1 after 2:00 p.m. EDT on May 9th
   

About Ebix, Inc.

A leading international supplier of On-Demand software and E-commerce services to the insurance, financial, e-governance and healthcare industries, Ebix, Inc. provides end-to-end on-Demand solutions ranging from infrastructure exchanges, front end & back end enterprise systems, outsourced administrative & custom software development solutions, and risk compliance solutions for various entities involved in these industries.

With 40+ offices across Australia, Brazil, Canada, India, New Zealand, Singapore, the US and the UK, Ebix powers multiple exchanges across the world in the field of life, annuity, health and property & casualty insurance while conducting in excess of $100 billion in insurance premiums annually on its platforms. Through its various SaaS-based software platforms, Ebix employs hundreds of domain specific business and technology professionals to provide products, support and consultancy to thousands of customers on six continents. For more information, visit the Company's website at www.ebix.com

SAFE HARBOR REGARDING FORWARD-LOOKING STATEMENTS
As used herein, the terms "Ebix," "the Company," "we," "our" and "us" refer to Ebix, Inc., a Delaware corporation, and its consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only Ebix, Inc.

The information contained in this Press Release contains forward-looking statements and information within the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. This information includes assumptions made by, and information currently available to management, including statements regarding future economic performance and financial condition, liquidity and capital resources, acceptance of the Company's products by the market, and management's plans and objectives. In addition, certain statements included in this and our future filings with the Securities and Exchange Commission ("SEC"), in press releases, and in oral and written statements made by us or with our approval, which are not statements of historical fact, are forward-looking statements. Words such as "may," "could," "should," "would," "believe," "expect," "anticipate," "estimate," "intend," "seeks," "plan," "project," "continue," "predict," "will," "should," and other words or expressions of similar meaning are intended by the Company to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are found at various places throughout this report and in the documents incorporated herein by reference. These statements are based on our current expectations about future events or results and information that is currently available to us, involve assumptions, risks, and uncertainties, and speak only as of the date on which such statements are made.

Our actual results may differ materially from those expressed or implied in these forward-looking statements. Factors that may cause such a difference, include, but are not limited to those discussed in our Annual Report on Form 10-K and subsequent reports filed with the SEC, as well as: the risk of an unfavorable outcome of the pending governmental investigations or shareholder class action lawsuits, reputational harm caused by such investigations and lawsuits, the willingness of independent insurance agencies to outsource their computer and other processing needs to third parties; pricing and other competitive pressures and the Company's ability to gain or maintain share of sales as a result of actions by competitors and others; changes in estimates in critical accounting judgments; changes in or failure to comply with laws and regulations, including accounting standards, taxation requirements (including tax rate changes, new tax laws and revised tax interpretations) in domestic or foreign jurisdictions; exchange rate fluctuations and other risks associated with investments and operations in foreign countries (particularly in Australia, UK and India wherein we have significant operations); equity markets, including market disruptions and significant interest rate fluctuations, which may impede our access to, or increase the cost of, external financing; and international conflict, including terrorist acts.

Except as expressly required by the federal securities laws, the Company undertakes no obligation to update any such factors, or to publicly announce the results of, or changes to any of the forward-looking statements contained herein to reflect future events, developments, changed circumstances, or for any other reason.

Readers should carefully review the disclosures and the risk factors described in the documents we file from time to time with the SEC, including future reports on Forms 10-Q and 8-K, and any amendments thereto.

You may obtain our SEC filings at our website, www.ebix.com under the "Investor Information" section, or over the Internet at the SEC's web site, www.sec.gov.

   
   
Ebix, Inc. and Subsidiaries  
Condensed Consolidated Statements of Income  
(In thousands, except per share data)  
(Unaudited)  
   
    Three Months Ended  
    March 31,  
    2017     2016  
Operating revenue   $ 79,103     $ 71,066  
                 
Operating expenses:                
Cost of services provided     25,187       19,602  
Product development     8,350       8,065  
Sales and marketing     4,337       4,333  
General and administrative, net     12,684       11,583  
Amortization and depreciation     2,855       2,720  
  Total operating expenses     53,413       46,303  
                 
  Operating income     25,690       24,763  
Interest income     774       143  
Interest expense     (2,468 )     (1,274 )
Foreign currency exchange gain     3,496       469  
Income before income taxes     27,492       24,101  
Income tax expense     (869 )     (1,750 )
Net income including noncontrolling interest     26,623       22,351  
Net income attributable to noncontrolling interest     196       192  
Net income attributable to Ebix, Inc.   $ 26,427     $ 22,159  
                 
Basic earnings per common share attributable to Ebix, Inc.   $ 0.83     $ 0.67  
                 
Diluted earnings per common share attributable to Ebix, Inc.   $ 0.83     $ 0.67  
                 
Basic weighted average shares outstanding     31,807       33,043  
                 
Diluted weighted average shares outstanding     31,973       33,310  
                 
                 
Ebix, Inc. and Subsidiaries  
Condensed Consolidated Balance Sheets  
(In thousands, except share amounts)  
   
    March 31,
 2017
    December 31,
 2016
 
ASSETS   (Unaudited)        
Current assets:                
Cash and cash equivalents   $ 120,195     $ 114,118  
Short-term investments     3,260       3,105  
Restricted cash     11,249       17,217  
Trade accounts receivable, less allowances of $2,962 and $2,833, respectively     68,424       62,713  
Other current assets     13,896       12,716  
  Total current assets     217,024       209,869  
                 
Property and equipment, net     38,823       37,061  
Goodwill     443,304       441,404  
Intangibles, net     39,683       41,336  
Indefinite-lived intangibles     30,887       30,887  
Capitalized software development costs, net     6,108       5,955  
Deferred tax asset, net     33,741       31,345  
Other assets     5,620       5,898  
Total assets   $ 815,190     $ 803,755  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY                
Current liabilities:                
Accounts payable and accrued liabilities   $ 23,948     $ 44,855  
Accrued payroll and related benefits     6,595       7,474  
Short term debt, net of deferred financing costs of $136, respectively     12,364       12,364  
Capital lease obligations     9       9  
Current deferred rent     285       281  
Contingent liability for accrued earn-out acquisition consideration     1,943       1,921  
Deferred revenue     23,643       22,564  
Other current liabilities     276       244  
  Total current liabilities     69,063       89,712  
                 
Revolving line of credit     194,029       154,029  
Long term debt and capital lease obligations, less current portion, net of deferred financing costs of $435 and $452, respectively     102,713       105,824  
Other liabilities     7,005       6,070  
Contingent liability for accrued earn-out acquisition consideration     6,810       6,589  
Deferred revenue     1,342       1,886  
Long term deferred rent     913       1,009  
Total liabilities     381,875       365,119  
                 
Commitments and Contingencies                
                 
Stockholders' equity:                
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at March 31, 2017 and December 31, 2016     --       --  
Common stock, $0.10 par value, 60,000,000 shares authorized, 31,524,369 issued and outstanding, at March 31, 2017 and 32,093,294 issued and outstanding at December 31, 2016     3,152       3,209  
Additional paid-in capital     --       --  
Retained earnings     447,824       457,364  
Accumulated other comprehensive loss     (31,160 )     (33,677 )
Total Ebix, Inc. stockholders' equity     419,816       426,896  
Noncontrolling interest     13,499       11,740  
Total stockholders' equity     433,315       438,636  
Total liabilities and stockholders' equity   $ 815,190     $ 803,755  
                 
                 
                 
Ebix, Inc. and Subsidiaries  
Condensed Consolidated Statements of Cash Flows  
(In thousands)  
(Unaudited)  
   
    Three Months Ended  
    March 31,  
    2017     2016  
Cash flows from operating activities:                
Net income attributable to Ebix, Inc.   $ 26,427     $ 22,159  
Net income attributable to noncontrolling interest     196       192  
Adjustments to reconcile net income to net cash provided by operating activities:                
Depreciation and amortization     2,855       2,720  
Benefit for deferred taxes     (850 )     (165 )
Share based compensation     686       647  
Provision for doubtful accounts     407       (241 )
Unrealized foreign exchange gain     (860 )     (48 )
Amortization of capitalized software development costs     410       326  
Reduction of acquisition earnout accruals     --       (511 )
Purchase accounting adjustment     (948 )     --  
Changes in assets and liabilities, net of effects from acquisitions:                
Accounts receivable     (5,661 )     (8,669 )
Other assets     112       (220 )
Accounts payable and accrued expenses     (7,118 )     (7,563 )
Accrued payroll and related benefits     (1,021 )     717  
Deferred revenue     382       1,258  
Deferred rent     (102 )     (80 )
Reserve for potential uncertain income tax return positions     518       50  
Other liabilities     268       (38 )
  Net cash provided by operating activities     15,701       10,534  
                 
Cash flows from investing activities:                
Capitalized software development costs     (514 )     (144 )
Purchases of marketable securities     (1,005 )     (596 )
Capital expenditures     (2,705 )     (1,028 )
  Net cash used in investing activities     (4,224 )     (1,768 )
                 
Cash flows from financing activities:                
Proceeds (repayments) from revolving line of credit, net     40,000       20,000  
Principal payments of term loan obligation     (3,125 )     --  
Repurchases of common stock     (40,517 )     (14,787 )
Proceeds from the exercise of stock options     52       29  
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested     (167 )     (66 )
Dividend payments     (2,428 )     (2,422 )
Payments of capital lease obligations     (1 )     --  
  Net cash provided by (used) in financing activities     (6,186 )     2,754  
Effect of foreign exchange rates on cash     786       321  
  Net change in cash and cash equivalents     6,077       11,841  
  Cash and cash equivalents at the beginning of the period     114,118       57,179  
  Cash and cash equivalents at the end of the period   $ 120,195     $ 69,020  
Supplemental disclosures of cash flow information:                
Interest paid   $ 2,289     $ 1,987  
Income taxes paid   $ 6,663     $ 7,015  
                 

CONTACT:

Darren Joseph
678 -281-2027
Email Contact

David Collins or Chris Eddy
Catalyst Global
212-924-9800
Email Contact


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: EarningsNewsPress Releases